2024
Real-World Use Patterns and Clinical Outcomes for Myelodysplastic Syndrome Patients Initiating Oral Decitabine and Cedazuridine or Intravenous/Subcutaneous Hypomethylating Agents
Zeidan A, Zhao R, Pierre-Victor D, Wang Y, Tepsick J, Lan Z, Salimi T. Real-World Use Patterns and Clinical Outcomes for Myelodysplastic Syndrome Patients Initiating Oral Decitabine and Cedazuridine or Intravenous/Subcutaneous Hypomethylating Agents. Blood 2024, 144: 5189-5189. DOI: 10.1182/blood-2024-205495.Peer-Reviewed Original ResearchAML-free survivalTreated with hypomethylating agentsOral hypomethylating agentsHypomethylating agentsMyelodysplastic syndrome patientsMyelodysplastic syndromeDEC-CClinical characteristicsMDS diagnosisNext treatmentMonths median follow-upRisk of AML transformationHigh-risk myelodysplastic syndromeReal-world treatment outcomesTreatment of adult patientsHypomethylating agent treatmentKaplan-Meier survival analysis methodMedian Follow-UpCox regression analysisReal-world studyAML transformationHMA therapyOral decitabineECOG 0Electronic health record database
2019
302. HCV Care in Federally Qualified Health Centers During the Opioid Epidemic: A Retrospective Cohort Study
Assoumou S, Wang J, Nolen S, Yazdi G, Mayer K, Puro J, Salomon J, Linas B. 302. HCV Care in Federally Qualified Health Centers During the Opioid Epidemic: A Retrospective Cohort Study. Open Forum Infectious Diseases 2019, 6: s163-s163. PMCID: PMC6810237, DOI: 10.1093/ofid/ofz360.375.Peer-Reviewed Original ResearchSustained virological responseHepatitis C virusIdentified OUDOpioid use disorderChronic hepatitis C virusTreatment initiationOpioid epidemicFederally Qualified Health CentersFactors associated with treatment initiationHepatitis C virus RNA testingReal-world treatment outcomesDiagnosis of opioid use disorderFactors associated with testingHepatitis C virus outcomeInclusion criteriaRetrospective cohort studyTreatment initiation ratesRetrospective cohort of adultsHepatitis C virus careAssociated with higher oddsCommercially insured patientsYears of ageCohort of adultsVirological responseRNA testing
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply